In this study, we use an insidious aAMD model, aged heterozygous complement factor H knockout (Cfh+/−) mice on a high‐fat diet (HFD)6 to determine the safety of IL‐33 treatment and demonstrate its potential as an early therapeutic for preventing AMD progression. Here, IL33 is linked to age-related macular degeneration.